Assessment of post-vaccination immunologic responses in inactivated virus COVID-19 respondents by Elisabeth L S. Setianingrum, Kartini Lidia, Kristian Ratu, Samson E Teron

Subjects: Get full text

COVID-19 Breakthrough Infection after Inactivated Vaccine Induced Robust Antibody Responses and Cross-Neutralization of SARS-CoV-2 Variants, but Less Immunity against Omicron by Nungruthai Suntronwong, Ritthideach Yorsaeng, Jiratchaya Puenpa, Chompoonut Auphimai, Thanunrat Thongmee, Preeyaporn Vichaiwattana, Sitthichai Kanokudom, Thaneeya Duangchinda, Warangkana Chantima, Pattarakul Pakchotanon, Suvichada Assawakosri, Pornjarim Nilyanimit, Sirapa Klinfueng, Lakkhana Wongsrisang, Donchida Srimuan, Thaksaporn Thatsanatorn, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Yong Poovorawan

Subjects: Get full text

High Doses of Inactivated African Swine Fever Virus Are Safe, but Do Not Confer Protection against a Virulent Challenge by Estefanía Cadenas-Fernández, Jose M. Sánchez-Vizcaíno, Erwin van den Born, Aleksandra Kosowska, Emma van Kilsdonk, Paloma Fernández-Pacheco, Carmina Gallardo, Marisa Arias, Jose A. Barasona

Subjects: Get full text

Abstract P-37: Phosphorous Mapping in Inactivated SARS-Cov-2 Particles by Electron Energy Loss Spectroscopy by Andrey Moiseenko, Lubov Kozlovskaya, Aydar Ishmukhametov, Alexey Egorov, Konstantin Shaitan, Mikhail Kirpichnikov, Olga Sokolova

Subjects: Get full text

Immunogenic properties of the preparation containing the Chikungunya virus antigen inactivated by β-propiolactone by G. M. Ignatyev, K. V. Kaa, L. P. Antonova, A. V. Atrasheuskaya, A. A. Ishmukhametov

Subjects: “…inactivated virus chikungunya antigen…”
Get full text

Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination by Noopur Bhatnagar, Ki-Hye Kim, Jeeva Subbiah, Sakinah Muhammad-Worsham, Bo Ryoung Park, Rong Liu, Phillip Grovenstein, Bao-Zhong Wang, Sang-Moo Kang

Subjects: Get full text

Chikungunya Vaccine Candidates: Current Landscape and Future Prospects by Schmidt C, Schnierle BS

Subjects: Get full text

Kinetics of the Neutralizing and Spike SARS-CoV-2 Antibodies following the Sinovac Inactivated Virus Vaccine Compared to the Pfizer mRNA Vaccine in Singapore by Chin Shern Lau, May Lin Helen Oh, Soon Kieng Phua, Ya Li Liang, Yanfeng Li, Jianxin Huo, Yuhan Huang, Biyan Zhang, Shengli Xu, Tar Choon Aw

Subjects: Get full text

Safety and Immunogenicity of a Booster Vaccination by CoronaVac or BNT162b2 in Previously Two-Dose Inactivated Virus Vaccinated Individuals with Negative Neutralizing Antibody by Kristi Tsz-Wan Lai, Emilie Yuen-Ting Lai Wan Loong, Terry Ling-Hiu Fung, Luke Wing-Pan Luk, Chor-Chiu Lau, Jonpaul Sze-Tsing Zee, Edmond Shiu-Kwan Ma, Bone Siu-Fai Tang

Subjects: Get full text

Side Effects of COVID-19 Inactivated Virus vs. Adenoviral Vector Vaccines: Experience of Algerian Healthcare Workers by Mohamed Lounis, Mohammed Amir Rais, Djihad Bencherit, Hani Amir Aouissi, Adda Oudjedi, Jitka Klugarová, Jitka Klugarová, Andrea Pokorná, Andrea Pokorná, Miloslav Klugar, Miloslav Klugar, Abanoub Riad, Abanoub Riad

Subjects: Get full text

Short-Term Adverse Effects Following Booster Dose of Inactivated-Virus vs. Adenoviral-Vector COVID-19 Vaccines in Algeria: A Cross-Sectional Study of the General Population by Mohamed Lounis, Hani Amir Aouissi, Samir Abdelhadi, Mohammed Amir Rais, Salem Belkessa, Djihad Bencherit

Subjects: Get full text

A Whole Virion Vaccine for COVID-19 Produced via a Novel Inactivation Method and Preliminary Demonstration of Efficacy in an Animal Challenge Model by Izabela K Ragan, Lindsay M Hartson, Taru S Dutt, Andres Obregon-Henao, Rachel M Maison, Paul Gordy, Amy Fox, Burton R Karger, Shaun T Cross, Marylee L Kapuscinski, Sarah K Cooper, Brendan K Podell, Mark D Stenglein, Richard A Bowen, Marcela Henao-Tamayo, Raymond P Goodrich

Subjects: Get full text

An effective inactivant based on singlet oxygen-mediated lipid oxidation implicates a new paradigm for broad-spectrum antivirals by Lei Zeng, Meng-Di Wang, Sheng-Li Ming, Guo-Li Li, Peng-Wei Yu, Yan-Li Qi, Da-Wei Jiang, Guo-Yu Yang, Jiang Wang, Bei-Bei Chu

Subjects: Get full text

Swine influenza A virus: challenges and novel vaccine strategies by Erika Petro-Turnquist, Erika Petro-Turnquist, Matthew J. Pekarek, Matthew J. Pekarek, Eric A. Weaver, Eric A. Weaver

Subjects: Get full text

Prevalence, Pathophysiology, and Treatment of Urticaria post-COVID-19 Vaccination: A Systematic Review by Ardhina Nugrahaeni, Rani Tiyas Budiyanti

Subjects: Get full text

What Would Jenner and Pasteur Have Done About COVID-19 Coronavirus? The Urges of a Vaccinologist by Clarisa B. Palatnik-de-Sousa, Clarisa B. Palatnik-de-Sousa

Subjects: Get full text

Myocarditis Following Inactivated SARS-CoV-2 Vaccine (Vero Cell) in an Adult Female in Vietnam: A Case Report by Tran H, Vu VH, Tran D, Pham QDD, Nguyen KD, Truong BQ

Subjects: Get full text

Virus replication is not required for oncolytic bovine herpesvirus-1 immunotherapy by Enzo Mongiovi Baracuhy, Olga Cormier, Maria Eugenia Davola, Susan Collins, Karen Mossman

Subjects: Get full text

Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccines by Moe H. Kyaw, Julia Spinardi, Ling Zhang, Helen May Lin Oh, Amit Srivastava

Subjects: Get full text

Development and Evaluation of a Novel One-Step RT-qPCR Targeting the Vero Gene for the Identification of False-Positive Results Caused by Inactivated Virus Vaccine Contamination by Xin-Qi Zheng, Wan-Bao Yang, Lin Xie, Zi-Han Wei, Jiang-Xing Zhuang, Tian-Ci Yang

Subjects: Get full text